Status:
RECRUITING
Molecular and Genetic Studies of Congenital Myopathies
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
Muscular Dystrophy Association
Conditions:
Central Core Disease
Centronuclear Myopathy
Eligibility:
All Genders
Brief Summary
In the Congenital Myopathy Research Program at Boston Children's Hospital and Harvard Medical School, the researchers are studying the congenital myopathies (neuromuscular diseases present from birth)...
Detailed Description
The Congenital Myopathy Research Program consists of a group of scientists and healthcare providers all working to better understand the congenital myopathies. We are taking two approaches to reach ou...
Eligibility Criteria
Inclusion
- Individuals with a clinical or suspected diagnosis of a congenital myopathy and their family members
Exclusion
- No specific exclusion criteria. Our studies do not include myotonia congenita or related conditions.
Key Trial Info
Start Date :
August 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2050
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT00272883
Start Date
August 1 2003
End Date
January 1 2050
Last Update
June 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Genetics Division, Boston Children's Hospital
Boston, Massachusetts, United States, 02115